How to test the authenticity of drugs

1, open the official website of the State Administration of Medical Supplies.

2. Click on "Drugs"

3. Enter what you want to query in the search box.

4. Click "Search" to query.

Extended data:

Development situation

1, new drugs are hard to find, and imitation drugs are hard to imitate.

"The existing research and development models and processes are increasingly difficult to find new drugs. On the basis of existing life science and technology, after rounds of screening, almost all known biochemical molecular reactions and biochemical enzyme reactions have been developed by the pharmaceutical industry. " John Duan, a senior FDA examiner and clinical pharmacologist, said.

The output rate of new drugs is declining, the research and development cost is rising, the clinical time is too long, and the listing process is too slow ... These cliches about drug innovation still exist, and the sustainability of domestic biopharmaceutical development is unsustainable because of weak foundation and lack of accumulation.

2, 2. Capital and technology are not completely connected.

In fact, due to the high growth of the pharmaceutical industry, a lot of funds revolve around medicine, but it is understood that the funds attracted by domestic biomedicine only account for about 5% of the whole medical financing.

In addition, most general financial investments hope to see benefits in a short time, while it takes a long time for a drug to go on the market. Even if it goes public, the follow-up risks still exist. Relatively speaking, strategic investment pays more attention to long-term benefits, and it can take several years to raise funds to help enterprises carry out strategic planning and management optimization.

3, looking for biomedical kindling

Zhang Faming, president of Sino-American Guanke Biotechnology (Beijing) Co., Ltd. believes that in the past, our research and development model was to look for a needle that could cure diseases in a pile of firewood with a magnifying glass. We need to set fire to unnecessary firewood, so all that's left is needles. In the research and development of new drugs, biomarkers are such matches that can burn straw.

The so-called biomarker is to find some characteristic biochemical indicators that can be objectively measured and evaluated through the study of genomics and oncology knowledge in a common physiological or pathological or therapeutic process, and to understand the current biological process of the body through them.

Source of reference: US Food and Drug Administration.